Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11457-11471

  Chan, Yee Peng ^a   Lu, Min ^b   Dutta, Somnath ^c   Yan, Lianying ^a   Barr, Jennifer ^d   Flora, Michael ^a   Feng, Yan Ru ^a   Xu, Kai ^e   Nikolov, Dimitar B ^e   Wang, Lin Fa ^d   Skiniotis, Georgios ^c,f   Broder, Christopher C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CSIRO   (Australia)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; HYBRID PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PEPTIDE; PHOSPHOLIPASE D; PROTEIN ANTIBODY; PROTEIN PRECURSOR; PROTEINASE; SF GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BIOCHEMISTRY; BIOENGINEERING; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; CROSS REACTION; CYTOPLASM; HENDRA VIRUS; HENDRA VIRUS INFECTION; HENIPAVIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; MOUSE; NIPAH VIRUS; NIPAH VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; VACCINE PRODUCTION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS REACTIONS; HELA CELLS; HENIPAVIRUS; HUMANS; MICE; MICROSCOPY, ELECTRON; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; VIRAL FUSION PROTEINS;

ANIMALIA; HENDRA VIRUS; HENIPAVIRUS; MUS; NIPAH VIRUS;

EID: 84868338568     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01318-12     Document Type: Article

References (73)

1. Aguilar HC, et al. 2007. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J. Virol. 81:4520-4532.
2. Aguilar HC, et al. 2006. N-Glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J.Virol. 80:4878-4889.
3. Anonymous. 2012. New Hendra virus case in Cairns area. Department of Agriculture, Fisheries and Forestry, Brisbane, Queensland, Australia.www.daff.qld.gov.au/30_21974.htm.
4. Anonymous. 2012. Nipah encephalitis, human-Bangladesh: Jipurhat.Pro-MED-mailArchive no. 20120212.1040138. February 7. International Society for Infectious Diseases, Brookline, MA. www.promedmail.org.
5. Arankalle VA, et al. 2011. Genomic characterization of Nipah virus, West Bengal, India. Emerg. Infect. Dis. 17:907-909.
6. Bernasconi E, Fasel N, Wittek R. 1996. Cell surface expression of a functional rubella virus E1 glycoprotein by addition of a GPI anchor. J.Cell Sci. 109(Pt 6):1195-1201.
7. Bishop KA, et al. 2007. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J. Virol. 81:5893-5901.
8. Bonaparte MI, et al. 2005. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc. Natl. Acad. Sci. U.S.A. 102:10652-10657.
9. Bossart KN, et al. 2005. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J. Virol. 79:6690-6702.
10. Bossart KN, et al. 2005. Inhibition of henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virol. J.2:57.
11. Bossart KN, Wang LF, Eaton BT, Broder CC. 2001. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology 290:121-135.
12. Bossart KN, et al. 2002. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins.J. Virol. 76:11186 -11198.
13. Breed AC, et al. 2010. Prevalence of henipavirus and rubulavirus antibodies in pteropid bats, Papua New Guinea. Emerg. Infect. Dis. 16:1997-1999.
14. Broder CC. 2012. Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Curr. Opin. Virol. 2:176-187.
15. Carter JR, Pager CT, Fowler SD, Dutch RE. 2005. Role of N-linked glycosylation of the Hendra virus fusion protein. J. Virol. 79:7922-7925.
16. Chadha MS, et al. 2006. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg. Infect. Dis. 12:235-240.
17. Chan YP, Yan L, Feng YR, Broder CC. 2009. Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery. Methods Mol. Biol. 525:31-58, xiii.
18. Chen L, et al. 2001. Cloning, expression, and crystallization of the fusion protein of Newcastle disease virus. Virology 290:290-299.
19. Chen L, et al. 2001. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure (Camb.) 9:255-266.
20. Chua KB, et al. 2000. Nipah virus: a recently emergent deadly paramyxovirus.Science 288:1432-1435.
21. Chua KB, et al. 2002. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 4:145-151.
22. Connolly SA, Leser GP, Jardetzky TS, Lamb RA. 2009. Bimolecular complementation of paramyxovirus fusion and hemagglutininneuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J. Virol. 83:10857-10868.
23. Connolly SA, Leser GP, Yin HS, Jardetzky TS, Lamb RA. 2006. Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc. Natl. Acad. Sci. U.S.A. 103:17903-17908.
24. Corey EA, Iorio RM. 2009. Measles virus attachment proteins with impaired ability to bind CD46 interact more efficiently with the homologous fusion protein. Virology 383:1-5.
25. Diederich S, Moll M, Klenk HD, Maisner A. 2005. The Nipah virus fusion protein is cleaved within the endosomal compartment. J. Biol.Chem. 280:29899-29903.
26. Drexler JF, et al. 2009. Henipavirus RNA in African bats. PLoS One 4:e6367. doi:10.1371/journal.pone.0006367.
27. Drexler JF, et al. 2012. Bats host major mammalian paramyxoviruses. Nat. Commun. 3:796.
28. Eaton BT, Broder CC, Middleton D, Wang LF. 2006. Hendra and Nipahviruses: different and dangerous. Nat. Rev. Microbiol. 4:23-35.
29. Eaton BT, Mackenzie JS, Wang L-F. 2007. Henipaviruses, p 1587-1600.In Knipe DM, et al. (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
30. Field HE, Mackenzie JS, Daszak P. 2007. Henipaviruses: emerging paramyxoviruses associated with fruit bats. Curr. Top. Microbiol. Immunol.315:133-159.
31. Gurley ES, et al. 2007. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg. Infect. Dis. 13:1031-1037.
32. Halpin K, et al. 2011. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission.Am. J. Trop. Med. Hyg. 85:946-951.
33. Harbury PB, Kim PS, Alber T. 1994. Crystal structure of an isoleucinezipper trimer. Nature 371:80-83.
34. Harcourt BH, et al. 2000. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271:334-349.
35. Hayman DT, et al. 2008. Evidence of henipavirus infection in West African fruit bats. PLoS One 3:e2739. doi:10.1371/journal.pone.0002739.
36. Homaira N, et al. 2010. Cluster of Nipah virus infection, Kushtia District,Bangladesh, 2007. PLoS One 5:e13570. doi:10.1371/journal. pone.0013570.Chan et al.11470
37. Hsu VP, et al. 2004. Nipah virus encephalitis reemergence, Bangladesh.Emerg. Infect. Dis. 10:2082-2087.
38. Johnson ML, Correia JJ, Yphantis DA, Halvorson HR. 1981. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques.Biophys. J. 36:575-588.
39. Kemble GW, Henis YI, White JM. 1993. GPI- and transmembraneanchored influenza hemagglutinin differ in structure and receptor binding activity. J. Cell Biol. 122:1253-1265.
40. Kyte J, Doolittle RF. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
41. Lamb RA, Parks GD. 2007. Paramyxoviridae: the viruses and their replication,p 1449-1496. In Knipe DM, et al. (ed), Fields virology, 5 ed, vol 1.Lippincott Williams & Wilkins, Philadelphia, PA.
42. Lamb RA, Paterson RG, Jardetzky TS. 2006. Paramyxovirus membranefusion: lessons from the F andHNatomic structures. Virology 344:30-37.
43. Laue TM, Shah BD, Ridgeway TM, Pelletier SL. 1992. Computer-aided interpretation of analytical sedimentation data for proteins, p 90-125. In Harding SE, Rowe AJ, Horton JC (ed), Analytical ultracentrifugation in biochemistry and polymer science. Royal Society of Chemistry, Cambridge,United Kingdom.
44. Lee B, Ataman ZA. 2011. Modes of paramyxovirus fusion: a henipavirus perspective. Trends Microbiol. 19:389-399.
45. Li Y, et al. 2008. Antibodies to Nipah or Nipah-like viruses in bats, China.Emerg. Infect. Dis. 14:1974-1976.
46. Luby SP, et al. 2009. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg. Infect. Dis. 15:1229-1235.
47. Ludtke SJ, Baldwin PR, Chiu W. 1999. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128:82-97.
48. Martin D, Calder LJ, Garcia-Barreno B, Skehel JJ, Melero JA. 2006.Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity. J. Gen. Virol. 87:1649-1658.
49. Melanson VR, Iorio RM. 2006. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J. Virol. 80:623- 633.
50. Melanson VR, Iorio RM. 2004. Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J. Virol. 78:13053-13061.
51. Meulendyke KA, Wurth MA, McCann RO, Dutch RE. 2005. Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79:12643-12649.
52. Michalski WP, Crameri G, Wang L, Shiell BJ, Eaton B. 2000. The cleavage activation and sites of glycosylation in the fusion protein of Hendra virus. Virus Res. 69:83-93.
53. Moll M, Kaufmann A, Maisner A. 2004. Influence of N-glycans on processing and biological activity of the Nipah virus fusion protein. J.Virol. 78:7274-7278.54. Murray K, et al. 1995. A morbillivirus that caused fatal disease in horses and humans. Science 268:94-97.
54. Murray K, et al. 1995. A morbillivirus that caused fatal disease in horses and humans. Science 268:94-97
55. Ohi M, Li Y, Cheng Y, Walz T. 2004. Negative staining and image classification-powerful tools in modern electron microscopy. Biol.Proced. Online 6:23-34.
56. Pager CT, Craft WW, Jr, Patch J, Dutch RE. 2006. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346:251-257.
57. Pager CT, Dutch RE. 2005. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79:12714-12720.
58. Pallister J, Middleton D, Broder CC, Wang LF. 2011. Henipavirus vaccine development. J. Bioterr. Biodef. S1:005. doi:10.4172/2157-2526.S1-005.
59. Plemper RK, Brindley MA, Iorio RM. 2011. Structural and mechanistic studies of measles virus illuminate paramyxovirus entry. PLoS Pathog.7:e1002058. doi:10.1371/journal.ppat.1002058.
60. Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R. 2002. Strength of envelope protein interaction modulates cytopathicity of measles virus. J. Virol. 76:5051-5061.
61. Reynes JM, et al. 2005. Nipah virus in Lyle's flying foxes, Cambodia.Emerg. Infect. Dis. 11:1042-1047.
62. Smith EC, Popa A, Chang A, Masante C, Dutch RE. 2009. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276: 7217-7227.
63. Smith I, et al. 2011. Identifying Hendra virus diversity in pteropid bats.PLoS One 6:e25275. doi:10.1371/journal.pone.0025275.
64. Steffen DL, Xu K, Nikolov DB, Broder CC. 2012. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses 4:280-308.
65. Swanson K, et al. 2010. Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology 402:372-379.
66. Ulbrandt ND, et al. 2006. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 80:7799-7806.
67. Wacharapluesadee S, et al. 2010. A longitudinal study of the prevalence of Nipah virus in Pteropus lylei bats in Thailand: evidence for seasonal preference in disease transmission. Vector Borne Zoonotic Dis. 10:183-190.
68. Wen X, et al. 2012. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site.Nat. Struct. Mol. Biol. 19:461- 463.
69. Xu K, Broder CC, Nikolov DB. 2012. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors. Semin. Cell Dev. Biol. 23:116-123.
70. Yang X, Farzan M, Wyatt R, Sodroski J. 2000. Characterization of stable,soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 74:5716-5725.
71. Yang X, et al. 2000. Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution. J. Virol. 74:4746-4754.
72. Yin HS, Paterson RG, Wen X, Lamb RA, Jardetzky TS. 2005. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein.Proc. Natl. Acad. Sci. U.S.A. 102:9288-9293.
73. Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS. 2006. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation.Nature 439:38-44.